USE OF INFLIXIMAB IN THE CASE OF INFLAMMATORY BOWEL DISEASE IN CHILDREN
Abstract
The Article is focused on the pressing issue, i.e. the therapy of inflammatory bowel diseases. It reviews in detail the aspects of using monoclonal antibodies to the tumor necrosis factor in the case of Crohn’s disease and unspecific ulcerative colitis. The article describes the results of the authors’ observations and provides data obtained by foreign researchers.
Key words: ulcerative colitis, Crohn’s disease, treatment, Infliximab, antibodies to the tumor necrosis factor, children.
(Pediatric Pharmacology. – 2010; 7(1):55-61)
About the Authors
N.E. ShchigolevaRussian Federation
I.A. Matina
Russian Federation
A.P. Ponomareva
Russian Federation
L.M. Karpina
Russian Federation
A.A. Bologov
Russian Federation
Review
For citations:
Shchigoleva N., Matina I., Ponomareva A., Karpina L., Bologov A. USE OF INFLIXIMAB IN THE CASE OF INFLAMMATORY BOWEL DISEASE IN CHILDREN. Pediatric pharmacology. 2010;7(1):55-61.
Email this article 